ESC Professional Premium Access

Measures of insulin resistance as a screening tool for dysglycaemia in patients with coronary artery disease. A report from the EUROASPIRE V population.

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Congress Presentation

About the speaker

Doctor Giulia Ferrannini

Karolinska Institute, Stockholm (Sweden)
2 presentations
0 follower

4 more presentations in this session

Diabetes and coronary risk equivalency - a population-based cohort study from Western Denmark

Speaker: Doctor K. Olesen (Aarhus, DK)


Quantity of adipose tissue and adipose tissue dysfunction and the risk of cancer in individuals at high risk of cardiovascular disease

Speaker: Ms M. Helmink (Utrecht, NL)


Endothelial dysfunction due to decreased nitric oxide bioavailability in dysglycaemic subjects and first-degree relatives of type 2 diabetic patients

Speaker: Doctor I. Ikonomidis (Athens, GR)


Metabolic syndrome and heart failure: 40 years follow up results of the Seven Countries Study

Speaker: Assistant Professor B. Parapid (Belgrade, RS)


Access the full session

Diabetes and the heart 1

Speakers: Doctor G. Ferrannini, Doctor K. Olesen, Ms M. Helmink, Doctor I. Ikonomidis, Assistant Professor B. Parapid

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by